** Shares in Elekta EKTAb.ST slump 14% to the bottom of
Europe's STOXX 600 .STOXX after the Swedish radiation therapy
equipment maker posted bigger-than-expected drop in Q4 profit
** Q4 adj. EBIT falls 22% to SEK 651 million ($62.5
million), missing consensus by 21% according to J.P.Morgan
** JPM ("underweight") points to a challenging market and
launch costs for Elekta Evo as results for the miss
** Elekta's CEO says he is not satisfied with Q4 outcome and
expects H1 of FY 2024/25 to be weaker as well due to challenging
market conditions
** The stock is on track for its worst day since February
2019 if losses hold
($1 = 10.4162 Swedish crowns)
(Reporting by Anna Chaberska)
((Anna.chaberska@thomsonreuters.com))